APTOCROM Inc. (KOSDAQ:109960)

South Korea flag South Korea · Delayed Price · Currency is KRW
172.00
-11.00 (-6.01%)
At close: Feb 27, 2026
Market Cap37.97B -59.1%
Revenue (ttm)12.15B -24.2%
Net Income-66.83B
EPS-344.36
Shares Out220.75M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,007,992
Average Volume1,273,067
Open181.00
Previous Close183.00
Day's Range167.00 - 182.00
52-Week Range167.00 - 591.00
Beta-0.13
RSI21.06
Earnings DateMar 13, 2026

About APTOCROM

APTOCROM Inc. distributes pharmaceutical products in South Korea. It offers prescription and over-the-counter medication, such as antibiotics, antifungal agent, antiviral drugs, infusion solution, peptic ulcer medication, osteoarthritis treatment, purifying solvent, brain function improvement agent, respiratory solvent, topical medicine, adrenocorticosteroids, urinary medicine, hair loss treatment, antipyretic analgesic and anti-inflammatory agent, antihistamines, obesity agents, neural contract, liver extract, fire extinguisher solvent, etc. T... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1998
Employees 14
Stock Exchange KOSDAQ
Ticker Symbol 109960
Full Company Profile

Financial Performance

Financial Statements